- Home
- / Minerva Biolabs
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Minerva Biolabs financials data including stock price, CreditSafe score, balance sheet, and acquistions and subsidiaries.
CreditSafe Score
?
Score changed on Jun 04, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| EUR | FY, 2016 | FY, 2017 | FY, 2018 |
|---|---|---|---|
| Cash | 413.7K | 256.7K | 145.6K |
| Inventories | 115.3K | 156.2K | 122.5K |
| Current Assets | 1.3M | 1.9M | 2.2M |
| PP&E | 376.0K | 298.9K | 822.3K |
| Total Assets | 1.7M | 2.2M | 3.1M |
| Total Liabilities | 195.0K | 337.8K | 584.3K |
| Common Stock | 25.6K | 25.6K | 25.6K |
| Additional Paid-in Capital | 260.1K | 403.2K | 598.7K |
| Total Equity | 1.5M | 1.9M | 2.5M |
| Financial Leverage | 1.1 | 1.2 | 1.2 |
Acquisitions & Subsidiaries
| Company name | Date | Deal size |
|---|---|---|
| Lorem | Dec 23, 2021 | $40.0M |
| Ipsum | Jan 18, 2022 | $30.0M |
| Lorem Ipsum | Feb 18, 2022 | $25.0M |
| Dolor | Oct 21, 2021 | $60.0M |
Premium Content only available in Craft’s Intelligence Portal View acquisitions and subsidiaries by company, date, and deal size. Understanding this data enables better supplier & customer negotiations and helps identify potential opportunities or market risks for your firm. Learn more |